William Kennedy Net Worth & Insider Trades

William Kennedy - Director, TG Therapeutics, Inc

As of June 24, 2020

What is William Kennedy's Net Worth?

The current estimated net worth of TG Therapeutics, Inc's Director, William Kennedy, is estimated to be about $2.59M . William Kennedy owns about 109,633 units of TG Therapeutics, Inc common stock. In the last 4 years at TG Therapeutics, Inc, William Kennedy has sold an estimated value of $566.49K worth.

What is William Kennedy's Past Insider Trading?

William Kennedy's largest sale order was 25,071 units , worth over $337.2K on June 18, 2018. In total, William Kennedy has made about 7 transactions over 4 years of their time at TG Therapeutics, Inc. William Kennedy usually trades in June, with the busiest year in 2017 and 2018. The most recent transaction was a sale order of 22,745 units , worth over $141.5K on June 24, 2020.

William Kennedy

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

What is William Kennedy's' Mailing Address?

  • Mailing address is C/o Xtl Biopharmaceuticals Ltd 711 Executive Blvd., Suite Q Valley Cottage NY 10989 NY

TG Therapeutics, Inc Executive Compensation

Name
Year
Salary
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Michael S. Weiss 2020 $1,392,470 $30,871,615 - $233,153 - $32,497,238
Michael S. Weiss 2019 $636,500 $8,397,186 $3,450,000 $191,040 - $12,674,726
Michael S. Weiss 2018 $655,625 $13,488,646 - $154,500 - $14,298,771
Sean A. Power 2020 $350,200 $6,610,300 - $159,341 - $7,119,841
Sean A. Power 2019 $340,000 - $345,000 $130,560 - $815,560
Sean A. Power 2018 $330,000 - $641,000 $105,600 - $1,076,600
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1001316/000155837021005391/tmb-20210616xdef14a.htm

What are TG Therapeutics, Inc's Past Insider Trades?

TG Therapeutics, Inc's most recent insider trade came on June 5, 2023 by Sean A Power who sold 73,647 units worth $1.97M . In the last 11 years, insiders at TG Therapeutics, Inc have sold an estimated value of $20.58M and bought an estimated value of $1.57M worth of shares. Insider trading is most common in June, with the busiest year in 2015 and 2013. The most active traders at the company are Sean A Power, Chief Financial Officer,  Michael S Weiss, CEO and President,  and Laurence N Charney, Director .

TG THERAPEUTICS, INC. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...